Park Yu Jin, Rim John Hoon, Yim Jisook, Lee Sang-Guk, Kim Jeong-Ho
Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Department of Medicine, Yonsei University Graduate School of Medicine, Seoul, Republic of Korea.
Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Clin Biochem. 2017 Aug;50(12):719-725. doi: 10.1016/j.clinbiochem.2017.02.023. Epub 2017 Feb 28.
The use of iodinated contrast media has grown in popularity in the past two decades, but relatively little attention has been paid to the possible interferential effects of contrast media on laboratory test results. Herein, we investigate medical contrast media interference with routine chemistry results obtained by three automated chemistry analyzers.
Ten levels of pooled serum were used in the study. Two types of medical contrast media [Iopamiro (iopamidol) and Omnipaque (iohexol)] were evaluated. To evaluate the dose-dependent effects of the contrast media, iopamidol and iohexol were spiked separately into aliquots of serum for final concentrations of 1.8%, 3.6%, 5.5%, 7.3%, and 9.1%. The 28 analytes included in the routine chemistry panel were measured by using Hitachi 7600, AU5800, and Cobas c702 analyzers. We calculated the delta percentage difference (DPD) between the samples and the control, and examined dose-dependent trends.
When the mean DPD values were compared with the reference cut-off criteria, the only uniformly interferential effect observed for all analyzers was in total protein with iopamidol. Two additional analytes that showed trends toward interferential effects only in few analyzers and exceeded the limits of the allowable error were the serum iron and the total CO. The other combinations of analyzer and contrast showed no consistent dose-dependent propensity for change in any analyte level.
Our study suggests that many of the analytes included in routine chemistry results, except total protein and serum iron, are not significantly affected by iopamidol and iohexol. These results suggest that it would be beneficial to apply a flexible medical evaluation process for patients requiring both laboratory tests and imaging studies, minimizing the need for strict regulations for sequential tests.
在过去二十年中,碘化造影剂的使用日益普遍,但造影剂对实验室检测结果可能产生的干扰作用相对较少受到关注。在此,我们研究医用造影剂对三种自动化学分析仪获得的常规化学检测结果的干扰情况。
本研究使用了十级混合血清。评估了两种类型的医用造影剂[碘帕醇(iopamidol)和欧乃派克(iohexol)]。为评估造影剂的剂量依赖性效应,将碘帕醇和碘海醇分别加入血清样本中,使其终浓度分别为1.8%、3.6%、5.5%、7.3%和9.1%。使用日立7600、AU5800和Cobas c702分析仪检测常规化学检测项目中的28种分析物。我们计算了样本与对照之间的差值百分比差异(DPD),并研究了剂量依赖性趋势。
当将平均DPD值与参考临界标准进行比较时,所有分析仪唯一一致观察到的干扰效应是碘帕醇对总蛋白的干扰。另外两种仅在少数分析仪中显示出干扰效应趋势且超出允许误差范围的分析物是血清铁和总二氧化碳。分析仪与造影剂的其他组合在任何分析物水平上均未显示出一致的剂量依赖性变化倾向。
我们的研究表明,常规化学检测结果中包含的许多分析物,除总蛋白和血清铁外,不受碘帕醇和碘海醇的显著影响。这些结果表明,对于需要同时进行实验室检测和影像学检查的患者,采用灵活的医学评估流程将是有益的,尽量减少对顺序检测严格规定的需求。